HLN Share Price Performance
HLN Community Fair Values
- AN
Consensus Narrative from 17 AnalystsSensodyne IND 20 And Cost Savings Will Strengthen Future Market Position
Key Takeaways Haleon is driving growth through innovation and international expansion in emerging markets, enhancing market share and revenue. Strategic divestments and efficiency programs aim to boost profitability, operational efficiency, and shareholder value.UK£4.18FV12.6% undervalued intrinsic discount2.45%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative28users have followed this narrative3 days ago author updated this narrative - UK£5.03FV27.4% undervalued intrinsic discount4.38%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative1users have followed this narrative10 days ago author updated this narrative
- UK£3.20FV14.1% overvalued intrinsic discount2.40%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative10 days ago author updated this narrative
Recent HLN News & Updates
No updates
Haleon plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 25, 2026
- Earnings per share (EPS)
- 0.17
- Gross Margin
- 63.56%
- Net Profit Margin
- 13.81%
- Debt/Equity Ratio
- 52.6%
Haleon plc Competitors
About HLN
- Founded
- 1715
- Employees
- 24561
- CEO
- WebsiteView website
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
U.K. Market Performance
- 7 Days: -2.5%
- 3 Months: 17.1%
- 1 Year: 12.4%
- Year to Date: 12.2%
Over the last 7 days, the market has dropped 2.5%, driven by a loss of 2.3% in the Financials sector. In contrast to the last week, the market is actually up 12% over the past year. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading